A complete application in a minute — tailored resume and cover letter, ready to send.
Immunome, Inc. in Washington state is seeking an experienced Senior Scientist II in ADME to lead the design and execution of nonclinical PK/PD and ADME programs, shaping candidate selection and regulatory submissions.
You will collaborate with cross-functional teams to integrate ADME insights into program strategy, mentor scientists, and stay current with evolving regulatory expectations.
The role offers a competitive salary and growth within a clinical-stage oncology portfolio leveraging ADCs.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.
TheScientistII/ Senior Scientist,ADMEwillcontributetothedesignandexecutionofnonclinical
Level andcompensationwillbecommensuratewith relevant experience.
Washington State Pay Range
$149,930 — $203,961 USD
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).